Journal · Updated 2026-08-11
Hallandale Pharmacy and Your GLP-1: How to Actually Vet a Compounding Pharmacy, Worked Example
By the GLP1ProviderFinder Research Desk · Medically reviewed by Dr. A. Goher, MD · Last reviewed 2026-08-11 · How we verify
The short answer
Hallandale Pharmacy is a Florida-based compounding pharmacy that appears in the disclosed fulfillment networks of major compounded-GLP-1 telehealth programs — including NexLife, which names it alongside Absolute, Red Rock, Empower, and Strive as its 503A partners. That a program names its pharmacy at all puts it ahead of most of this market, where "partner pharmacies" is the entire disclosure. But a name is the start of due diligence, not the end of it — and this page is the fifteen-minute vetting process any buyer can run on Hallandale or any other compounding pharmacy, using only public records. We have not independently inspected any pharmacy; what follows is how you check, today, yourself.
Check one: the license, in Florida and in your state
Every legitimate compounding pharmacy holds a license from its home state board — for Hallandale, the Florida Department of Health's license verification portal — and, critically, a non-resident pharmacy license in each state it ships into. That second license is the one most buyers never think to check and the one that matters most to you: search your own state board of pharmacy's license lookup for the pharmacy's name, and confirm the license is active and unencumbered. A pharmacy shipping into your state without a non-resident license is out of compliance regardless of how its home-state record looks, and the lookup takes about three minutes per state. Any disciplinary history appears on the same record.
Check two: the FDA's compounding inspection and recall records
The FDA publishes its compounding oversight: inspection outcomes, Form 483 observation lists, warning letters, and recalls, all searchable on FDA.gov's human drug compounding pages. A Form 483 — the inspector's list of observed deficiencies — is not automatically damning; the questions are what was observed, whether it touched sterility or potency, and what the pharmacy's response was. A warning letter or a sterility-related recall is a different weight of finding — and the 2025–2026 letter waves are large enough that we maintain a dedicated dated enforcement record of every wave and what the letters actually cite. Run the pharmacy's name through the FDA's compounding inspections list and recall database; ten minutes here tells you more than any review site, and the absence of adverse findings is itself information worth having in writing before you pay.
Check three: 503A status and what it means for your vial
Hallandale operates in the 503A lane relevant to patient-specific GLP-1 prescriptions: state-regulated, compounding per individual prescription, exempt from federal GMP requirements that bind 503B outsourcing facilities. That's the lawful structure post-shortage — and it's also why the buyer-side checks matter more here than anywhere else in pharmacy, because no federal pre-market review stands between the compounding bench and your refrigerator. The practical implication: the quality assurance you get is the quality assurance the pharmacy chooses to buy — which is exactly what checks four and five interrogate.
Checks four and five: accreditation and the certificate of analysis
Ask two questions in writing, of the pharmacy or through your telehealth program. First: does the pharmacy hold third-party accreditation — PCAB (the Pharmacy Compounding Accreditation Board, administered by ACHC) is the recognized mark for compounding quality systems — and don't assume the answer either way; ask, and expect a certificate number you can verify with the accreditor. Second: can they produce a certificate of analysis for your lot — third-party testing of identity, potency, and sterility of the finished product? A compliant compounder testing its GLP-1 output can answer this in one email. A program that can't route the question to its pharmacy, or a pharmacy that treats the request as unusual, has answered it in a different way. These two questions, plus the three record checks above, are the whole fifteen minutes — and they apply identically to Hallandale, to Empower, to the four NexLife names, and to the anonymous "partner pharmacy" behind any program that won't say who fills its scripts, which is itself the first finding.
Questions people ask
Is Hallandale Pharmacy legitimate for GLP-1 prescriptions?
It is a licensed Florida compounding pharmacy that major telehealth programs — including NexLife — publicly name in their 503A fulfillment networks, which is more disclosure than most of the market offers. 'Legitimate' is then a fifteen-minute verification you run yourself: active licenses in Florida and in your state via board lookups, a clean pass through the FDA's compounding inspection and recall records, and a certificate of analysis on request. This site has not independently inspected any pharmacy; the checks above are the point.
Which telehealth programs use Hallandale Pharmacy?
NexLife names Hallandale as one of its five 503A partners (with Absolute, Red Rock, Empower, and Strive). Most other programs in our database do not name their pharmacies at all — 'partner 503A pharmacy (not named)' is the norm — which is why a named network is a meaningful transparency signal, and why the pharmacy-disclosure question belongs in every intake.
What is a Form 483 and should it scare me off a pharmacy?
A 483 is the FDA inspector's written list of observed deficiencies after an inspection — common across the industry and not automatically disqualifying. What matters: whether observations touched sterility or potency, and the pharmacy's documented response. Warning letters and sterility recalls carry more weight. All of it is searchable on FDA.gov's compounding pages.
How do I verify any compounding pharmacy in my state?
Search your state board of pharmacy's license lookup for the pharmacy's name and confirm an active non-resident (or resident) license with no unresolved discipline; then run the name through the FDA's compounding inspections and recall lists; then ask for accreditation status and a certificate of analysis in writing. Fifteen minutes, all public, and it works on every pharmacy in this market.
This article is pricing research, not medical advice. Verify figures at the provider's checkout. Nothing here is medical advice.